Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8194634rdf:typepubmed:Citationlld:pubmed
pubmed-article:8194634lifeskim:mentionsumls-concept:C0549383lld:lifeskim
pubmed-article:8194634lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:8194634lifeskim:mentionsumls-concept:C0872104lld:lifeskim
pubmed-article:8194634pubmed:issue6lld:pubmed
pubmed-article:8194634pubmed:dateCreated1994-6-30lld:pubmed
pubmed-article:8194634pubmed:abstractTextControlled ovarian hyperstimulation was given to a study group consisting of male factor, endometriosis, and unexplained infertility. The aim of the study was to determine whether COH might be of value for such couples in a setting lacking ART facilities. When compared with their own spontaneous cycles or with a control group (untreated but scanned), COH proved significantly better for unexplained infertility. However, COH was not significantly effective for male factor infertility. This study shows that COH should be offered routinely in general hospitals to couples on long-term waiting lists for ART (especially those facing enforced expectant management).lld:pubmed
pubmed-article:8194634pubmed:languageenglld:pubmed
pubmed-article:8194634pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8194634pubmed:citationSubsetIMlld:pubmed
pubmed-article:8194634pubmed:statusMEDLINElld:pubmed
pubmed-article:8194634pubmed:monthJunlld:pubmed
pubmed-article:8194634pubmed:issn0015-0282lld:pubmed
pubmed-article:8194634pubmed:authorpubmed-author:DaviesW AWAlld:pubmed
pubmed-article:8194634pubmed:authorpubmed-author:LeeSSlld:pubmed
pubmed-article:8194634pubmed:authorpubmed-author:MascarenhasLLlld:pubmed
pubmed-article:8194634pubmed:authorpubmed-author:KhastgirGGlld:pubmed
pubmed-article:8194634pubmed:issnTypePrintlld:pubmed
pubmed-article:8194634pubmed:volume61lld:pubmed
pubmed-article:8194634pubmed:ownerNLMlld:pubmed
pubmed-article:8194634pubmed:authorsCompleteYlld:pubmed
pubmed-article:8194634pubmed:pagination1158-60lld:pubmed
pubmed-article:8194634pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:meshHeadingpubmed-meshheading:8194634-...lld:pubmed
pubmed-article:8194634pubmed:year1994lld:pubmed
pubmed-article:8194634pubmed:articleTitleControlled ovarian hyperstimulation: an adjunct to assisted reproductive technology.lld:pubmed
pubmed-article:8194634pubmed:affiliationNorthampton General Hospital, London, United Kingdom.lld:pubmed
pubmed-article:8194634pubmed:publicationTypeJournal Articlelld:pubmed